The addition of brachytherapy can further improve the results.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Lobectomy is the standard treatment in the early stages of non-small cell lung cancer.
📊
Key Findings & Data:Sublobar resection remains a treatment option in elderly patientswith low cardiopulmonary reserve who cannot tolerate sublobar resection lobectomy.
💡
Conclusion & Impact:The addition of brachytherapy can further improve the results.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Lobectomy is the standard treatment in the early stages of non-small cell lung cancer. Today, however, it is questioned whetherlobectomy should be performed in all early diagnosed patients. Sublobar resection remains a treatment option in elderly patientswith low cardiopulmonary reserve who cannot tolerate sublobar resection lobectomy. In small tumors measuring 2 cm in diameter,sublobar resections can provide local recurrence rates and long survival rates equivalent to lobectomy when performed withthe appropriate techniques in eligible patients. The addition of brachytherapy can further improve the results.
🔖
Cite This Article
AVCI, A., ÖZÇELİK, C. (2022). The Role of Sublobar Resections in the Treatment of Small Cell Lung Cancer. European Journal of Therapeutics, Cilt: 24 - Sayı: 1, 29–32. https://ajindex.com/articles/512338
Ginsberg RJ, Rubinstein LV. Randomized Trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Ann Thorac Surg 1995
[CrossRef] Wada H, Nakamura T, Nakamoto K, Maeda M, Watanabe Y. Thirty day operative mortality for thoracotomy in lung cancer. J Thorac Cardiovasc Surg 1998
[CrossRef] Keenan RJ, Landreneau RJ, Maley RH, Singh D, Macherey R, Bartley S, et al. Segmental resection spares pulmonary function in patients with stage I lung cancer. Ann Thorac Surg 2004
[CrossRef] Martin-Ucar AE, Nakas A, Pilling JE, West KJ, Waller DA. A casematched study of anatomical segmentectomy versus lobectomy for stage I lung cancer in high-risk patients. Eur J Cardiothorac Surg 2005
[CrossRef] El-Sherif A, Gooding WE, Santos R, Pettiford B, Ferson PF, Fernando HC, et al. Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: A 13-year analysis. Ann Thorac Surg 2006
[CrossRef] Hou B, Deng XF, Zhou D, Liu QX, Dai JG. Segmentectomy versus wedge resection for the treatment of high-risk operable patients with stage I non-small cell lung cancer: a meta-analysis. Ther Adv Respir Dis 2016
[CrossRef] Cerfolio RJ, Bryant AS. Survival and outcomes of pulmonary resection for non-small cell lung cancer in the elderly: a nested case-control study. Ann Thorac Surg 2006
[CrossRef] Groth SS, Rueth NM, Hodges JS, Habermann EB, Andrade RS, D’Cunha J, et al. Conditional cancer-specific versus cardiovascular-specific survival after lobectomy for stage I non-small cell lung cancer. Ann Thorac Surg 2010
[CrossRef] Dell’Amore A, Monteverde M, Martucci N, Sanna S, Caroli G, Dolci G, et al. Lobar and sub-lobar lung resection in octogenarians with early stage non-small cell lung cancer: factors affecting surgical outcomes and long-term results. Gen Thorac Cardiovasc Surg 2015
[CrossRef] Kilic A, Schuchert MJ, Pettiford BL, Pennathur A, Landreneau JR, Landreneau JP, et al.Anatomic segmentectomy for stage I nonsmall cell lung cancer (NSCLC) in the elderly Ann Thorac Surg, 2009
87(6):1662-1666 [CrossRef] Okada M, Nishio W, Sakamoto T, Uchino K, Yuki T, Nakagawa A, et al. Effect of tumor size on prognosis in patients with non-small cell lung cancer: The role of segmentectomy as a type of lesser resection J Thorac Cardiovasc Surg 2005
[CrossRef] Okada M, Koike T, Higashiyama M, Yamato Y, Kodama K, Tsubota N. Radical sublob